FOR IMMEDIATE RELEASE
(TAMPA, FLORIDA, USA, 11 October 2012) – The 2012 ISPE Annual Meeting will feature an all-new education program and new enhancements that are reflective of the organization’s new strategic plan, which emphasizes interaction and cooperation between pharmaceutical industry leaders and regulatory authorities, increased emphasis on product quality and patient safety and a focus on the entire product lifecycle. The four-day meeting will take place 11 – 14 November in San Francisco, Calif. USA.
“ISPE has made it a priority to expand our overall educational offerings to include more regulatory and strategic discussions as part of our transition to an approach that considers the entire product lifecycle,” said ISPE President and CEO Nancy Berg. “This year’s Annual Meeting education program reflects that, and as a result, we are seeing record-setting global registrations. This year’s meeting will be a brand-new experience for our Members and the industry professionals and regulators who attend.”
Among the elevated offerings at this year’s Annual Meeting are a plenary session with presentations from the FDA’s Dr. Stephen Spielberg and the IMS Institute for Healthcare Informatics’ Murray Aitken, an Executive Series and an International Regulatory Summit. Many education sessions, including those in the Executive Series, are expected to fill to capacity in the coming weeks.
The enhanced education program and International Regulatory Summit at the 2012 ISPE Annual Meeting are also drawing a record number of regulators as both speakers and attendees. In addition to Dr. Stephen Speilberg, confirmed regulators from the US FDA to-date include Jeffrey Baker, Ilisa Bernstein, Rick Friedman, Bogdan Kurtyka, Steve Lynn, Christina Moore, Yingxu Ping and Lawrence Yu. Other confirmed regulators include Mark Birse (MHRA), Joyce N. Cirunay (FDA Philippines), Dr. Rodolfo Mocchetto (ANMAT), Song Shufen and Liu Yuan (CCD, SFDA), among others.
ISPE has released a new video to highlight the program enhancements delegates will see at this year’s meeting. Additional information, including complete program, speaker, and registration information, is available on the 2012 ISPE Annual Meeting website.
ISPE, the International Society for Pharmaceutical Engineering, is a not-for-profit Society of 22,000 pharmaceutical professionals in 90 countries who use expert knowledge to create high-quality, cost-effective GMP solutions. ISPE will soon be recognized globally as the leading technical organization for professionals engaged in producing quality medicines and pharmaceutical devices across the entire product lifecycle. Founded in 1980, ISPE offers online learning opportunities for a global audience and has its worldwide headquarters in Tampa, Florida, USA, as well as offices in Brussels, Belgium, Singapore and Shanghai, China. Visit www.ISPE.org for additional Society news and information.
FDA Office of Pharmaceutical Quality Initiatives & 2016 Priorities
Friday, 24 Jun 2016 12.06
Interdisciplinary Perspectives on Key Pharma Industry Trends
Thursday, 23 Jun 2016 15.06
Endless Opportunities to Expand Your Knowledge & Network
Wednesday, 22 Jun 2016 12.06